Issuer · CIK 0001818794
DYN — Dyne Therapeutics, Inc.
⚡ SELL CLUSTER · last 7 days
2 insiders sold $18.9K of $DYN on Jun 17, 2026.
Cluster patterns historically carry stronger directional signal than any single insider trade. Read the methodology →
Kerr Douglas
Chief Medical Officer
$16.3K
Jun 17, 2026
Friedl-Naderer Johanna
Chief Commercial Officer
$2.7K
Jun 17, 2026
Recent filings
- Jun 17, 2026·Form 4·Sell$16.3K
DYN/Dyne Therapeutics, Inc.
Kerr Douglas · Chief Medical Officer
Mechanical filing
AI thesis skipped - Jun 17, 2026·Form 4·Sell$2.7K
DYN/Dyne Therapeutics, Inc.
Friedl-Naderer Johanna · Chief Commercial Officer
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other—
DYN/Dyne Therapeutics, Inc.
HURWITZ EDWARD · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other—
DYN/Dyne Therapeutics, Inc.
Lubner David Charles · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other—
DYN/Dyne Therapeutics, Inc.
Rhodes Jason P · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other—
DYN/Dyne Therapeutics, Inc.
Kersten Dirk · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other—
DYN/Dyne Therapeutics, Inc.
Incerti Carlo · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other—
DYN/Dyne Therapeutics, Inc.
Stehman-Breen Catherine · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Buy$33.9K
DYN/Dyne Therapeutics, Inc.
Posner Brian S · director
Mechanical filing
AI thesis skipped - Jun 5, 2026·Form 4·Buy$43.7K
DYN/Dyne Therapeutics, Inc.
Posner Brian S · director
Mechanical filing
AI thesis skipped - May 28, 2026·Form 4·Buy$36.4K
DYN/Dyne Therapeutics, Inc.
Posner Brian S · director
Mechanical filing
AI thesis skipped - May 14, 2026·Form 4·Sell$4.2K
DYN/Dyne Therapeutics, Inc.
Friedl-Naderer Johanna · Chief Commercial Officer
8conviction - May 14, 2026·Form 4·Sell$28.7K
DYN/Dyne Therapeutics, Inc.
Kerr Douglas · Chief Medical Officer
18conviction - May 14, 2026·Form 4·Sell$26.6K
DYN/Dyne Therapeutics, Inc.
Lucera Erick · Chief Financial Officer
22conviction - May 14, 2026·Form 4·Sell$60.8K
DYN/Dyne Therapeutics, Inc.
Cox John · CEO & President
28conviction - May 6, 2026·Form 4·Sell$793K
DYN/Dyne Therapeutics, Inc.
Rhodes Jason P · director
18conviction - Apr 30, 2026·Form 4·Sell$2.2M
DYN/Dyne Therapeutics, Inc.
Rhodes Jason P · director
28conviction